A survey among dermatologists: diagnostics of superficial fungal infections – what is used and what is needed to initiate therapy and assess efficacy?
Open Access
- 23 November 2018
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 33 (2) , 421-427
Abstract
Background: Superficial fungal infections are common. It is important to confirm the clinical diagnosis by mycological laboratory methods before initiating systemic antifungal treatment, especially as antifungal sensitivity and in vitro susceptibility may differ between different genera and species. For many years, the gold standard for diagnosis of superficial fungal infections has been direct fungal detection in the clinical specimen (microscopy) supplemented by culturing. Lately, newer molecular based methods for fungal identification have been developed.Objective: This study was initiated to focus on the current usage of mycological diagnostics for superficial fungal infections by dermatologists. It was designed to investigate whether it was necessary to differentiate between initial diagnostic tests and those used at treatment follow‐up in specific superficial fungal infections.Methods: An online questionnaire was distributed among members of the EADV mycology Task Force and other dermatologists with a special interest in mycology and nail disease.Results: The survey was distributed to 62 dermatologists of whom 38 (61%) completed the whole survey, 7 (11%) partially completed and 17 (27%) did not respond. Nearly, all respondents (82–100%) said that ideally they would use the result of direct microscopy (or histology) combined with a genus/species directed treatment of onychomycosis, dermatophytosis, Candida‐ and Malassezia‐related infections. The majority of the dermatologists used a combination of clinical assessment and direct microscopy for treatment assessment and the viability of the fungus was considered more important at this visit than when initiating the treatment. Molecular based methods were not available for all responders.Conclusion: The available diagnostic methods are heterogeneous and their usage differs between different practices as well as between countries. The survey confirmed that dermatologists find it important to make a mycological diagnosis, particularly prior to starting oral antifungal treatment in order to confirm the diagnose and target the therapy according to genus and species.Keywords
This publication has 18 references indexed in Scilit:
- Evaluation of the Bruker Matrix-Assisted Laser Desorption–Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) System for the Identification of Clinically Important Dermatophyte SpeciesMycopathologia, 2015
- Diagnostische PCR für Dermatophyten – ein ÜberblickJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2012
- Diagnostic PCR of dermatophytes – an overviewJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2012
- Molecular diagnosis of dermatophyte infectionsCurrent Opinion in Infectious Diseases, 2012
- Épidémiologie et prise en charge des onychomycoses en pratique dermatologique libérale en FranceAnnales de Dermatologie et de Vénéréologie, 2008
- Use of diagnostic tests by dermatologists, podiatrists and family practitioners in the United States: pilot data from a cross‐sectional surveyMycoses, 2007
- Five-Hour Diagnosis of Dermatophyte Nail Infections with Specific Detection ofTrichophyton rubrumJournal of Clinical Microbiology, 2007
- Epidemiology and clinical classification of onychomycosisJournal of the European Academy of Dermatology and Venereology, 2005
- PCR Identification of Trichophyton Mentagrophytes Var. Interdigitale And T. Mentagrophytes var. Mentagrophytes Dermatophytes with a Random PrimerJournal of Medical Microbiology, 1997
- Use of arbitrarily primed polymerase chain reaction to differentiateTrichophytondermatophytesFEMS Microbiology Letters, 1996